Search results
Results from the WOW.Com Content Network
Voriconazole, sold under the brand name Vfend among others, is an antifungal medication used to treat a number of fungal infections. [5] This includes aspergillosis, candidiasis, coccidioidomycosis, histoplasmosis, penicilliosis, and infections by Scedosporium or Fusarium. [5] It can be taken by mouth or used by injection into a vein. [5]
Itraconazole (R51211), invented in 1984, is a triazole fungistatic antifungal agent prescribed to patients with fungal infections. The drug may be given orally or intravenously. Itraconazole has a broader spectrum of activity than fluconazole (but not as broad as voriconazole or posaconazole).
Posaconazole is used to treat invasive Aspergillus and Candida infections. [5] It is also used for the treatment of oropharyngeal candidiasis (OPC), including OPC refractory to itraconazole and/or fluconazole therapy. [5] It is also used to treat invasive infections by Candida, Mucor, and Aspergillus species in severely immunocompromised ...
Miconazole is a widely used topical antifungal medication for the treatment of many fungal infections, namely skin infections, nail infections and vaginal candidiasis. The drug is usually formulated in creams, powders and sprays. However, it is suggested that patients developing acute porphyrias should avoid using this drug.
Infections are often fatal because of A. felis being identified as another cryptic Aspergillus species. Indeed, the right treatment is delayed leading to fatal issues. The primary therapy that has been used for invasive aspergillosis in humans was voriconazole, with isavuconazole and amphotericin B as alternatives for treatment failures. [3]
An antifungal medication, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others.
Seasonal flu activity is elevated across most of the country, according to the latest reports from the Centers for Disease Control and Prevention, and experts say this is expected to continue for ...
Intravenous oral therapy by voriconazole has been used successfully in the treatment of invasive aspergillosis. [5] Although voriconazole is most recommended, amphotericin B deoxycholate is a suitable alternative option for patients intolerant of voriconazole. [5] Hospital acquired infections by this species have been reported.